We recently published an article titled Jim Cramer’s Latest Lightning Round: 8 Stocks in Focus. In this article, we are going ...

The news sent Roche's stock up more than 4% in trading Wednesday, and Zealand's stock skyrocketed 40% on the news. Meanwhile, Novo Nordisk's stock was hit, sliding 4%, and Eli Lilly's stock was down ...

Analysts, who are highly bullish on the stock, have fretted for some time that Viking needed a partner to actually make the product, assuming it gains regulatory approval. Viking ...

Roche agreed to develop a weight-loss drug with Danish biotech Zealand Pharma, pressuring Novo Nordisk and Eli Lilly.

When a stock is in a freefall, there's usually a justifiable reason for the decline. But for investors with a high risk ...

Health care stocks returned -9.75% in the final quarter of 2024, according to the MSCI U.S. IMI Health Care 25/50 Index, ...

Viking announced a supply deal with CordenPharma that sets it up for a standalone path to the obesity market. Read why I ...

Trump said he would increase from 25% to 50% tariffs taking effect Wednesday for Canada after Ontario said it would raise ...

The president's tariffs are intended to pressure Mexico and Canada to help slow the flow of fentanyl, according to ...

Another horrible day in the stock market yesterday, but don’t worry: The president is on the case. Politico shares that Trump ...

The stock market fell yesterday as investors worry that Trump's tariffs will slow the economy and possibly lead the U.S. into ...

NanoViricides, Inc. (the “Company”)(NYSE American:NNVC), a clinical-stage global leader developing revolutionary broad-spectrum antiviral drugs that the viruses cannot escape, declared today that its ...